The mitochondrial electron transport chain (ETC) supports myriad, mechanistically linked functions. It provides the driving force for ATP synthesis by oxidative phosphorylation (OXPHOS) (Mitchell, 1961; Mitchell, 2011), maintains redox balance of cofactor pairs (NADH:NAD⁺, CoQH₂:CoQ) that are coupled to hundreds of cellular reactions (Williamson et al., 1967; Ying, 2008; Santidrian et al., 2013; Titov et al., 2016; Xiao et al., 2018; Goodman et al., 2018; Mitchell, 1975; Turunen et al., 2004; Alcázar-Fabra et al., 2016), contributes to the electrochemical gradient that drives transport of proteins and metabolites across the mitochondrial inner-membrane (LaNoue and Schoolwerth, 1979; Martin et al., 1991), and is a major determinant of cellular oxygen levels and tolerance (Taivassalo et al., 2002; Campian et al., 2004; O'Hagan et al., 2009; Brand, 2016; Jain et al., 2019). Defects in the ETC and OXPHOS system are associated with a spectrum of human pathology ranging from individually rare genetic disorders to common conditions, such as neurodegeneration (Schapira, 2008; Hu and Wang, 2016; Lin and Beal, 2006; Area-Gomez et al., 2019), diabetes (Kelley et al., 2002; Mootha et al., 2004; Ritov et al., 2005; Ritov et al., 2010), select forms of cancer (Wallace, 2012; Reznik et al., 2017; Gaude and Frezza, 2014) and the aging process itself (Sun et al., 2016; Bratic and Larsson, 2013).

Mutations in nearly 300 nuclear or mitochondrial (mtDNA) genes have been implicated in mitochondrial disorders that affect at least 1 in 4300 live births and lack effective treatments (Schapira, 2012; Vafai and Mootha, 2012; Gorman et al., 2015; Gorman et al., 2016; Frazier et al., 2019). Management of these conditions is complicated by their striking heterogeneity. They can develop acutely or progressively and can impact multiple organ systems or just a single cell type. Disease often manifests in post-mitotic tissues, such as skeletal muscle or the nervous system, but this pattern does not simply correlate with ATP demand or tissue expression of the causal gene. Deciphering how cells sense and respond to mitochondrial dysfunction is thus a major challenge with the potential to inform the common conditions that exhibit a decline in mitochondrial health.

Studies in patients, animals and cultured cells have consistently identified a gene expression program associated with the integrated stress response (ISR) as a signature of mitochondrial dysfunction (Martinus et al., 1996; Zhao et al., 2002; Kühl et al., 2017; Celardo et al., 2017; Quirós et al., 2017; Fujita et al., 2007; Silva et al., 2009; Tyynismaa et al., 2010; Dogan et al., 2014; Bao et al., 2016; Magarin et al., 2016; Lehtonen et al., 2016; Khan et al., 2017). The ISR is triggered by various insults, including nutrient deficiency, unfolded protein stress and pathogen infection. In mammalian cells, it is typically activated by a family of four kinases, each of which can phosphorylate the alpha subunit of translation initiation factor 2 (eIF2α) in response to distinct stimuli. eIF2α phosphorylation acutely inhibits global protein synthesis but promotes translation of transcription factors, such as activating transcription factor 4 (ATF4) and DNA damage-inducible transcript three protein (DDIT3), that then engage their downstream targets (Harding et al., 2003; Palam et al., 2011; Harding et al., 2000; Vattem and Wek, 2004; Wek, 2018; Pakos‐Zebrucka et al., 2016; Taniuchi et al., 2016).

The transcriptional program induced by the ISR varies across species and cell types and depends on the underlying trigger. Nevertheless, it frequently encompasses amino acid transport and biosynthesis genes, cytosolic tRNA synthetases and translation factors, pro-apoptotic factors, and genes involved in antioxidant defense, proteostasis and organelle quality control (Harding et al., 2003; Han et al., 2013). In tissues affected by mitochondrial disease, the ISR activates the mitochondrial 1-carbon pathway (Kühl et al., 2017; Tyynismaa et al., 2010; Bao et al., 2016; Nikkanen et al., 2016) and is thought to underlie secretion of the circulating cytokines fibroblast growth factor 21 (FGF21) and growth/differentiation factor 15 (GDF15) that are under consideration as disease biomarkers (Lehtonen et al., 2016; Fujita et al., 2015; Yatsuga et al., 2015; Chung et al., 2017; Miyake et al., 2016; Restelli et al., 2018). It remains unclear whether the ISR plays a protective role in mitochondrial disease or rather contributes to pathology (Khan et al., 2017; Suomalainen and Battersby, 2018; Lamech and Haynes, 2015).

How mitochondrial dysfunction is sensed to trigger the ISR is a major open question. Defects in mtDNA maintenance and expression are most frequently associated with ISR activation in vivo (Kühl et al., 2017; Lehtonen et al., 2016). However, such defects are expected to impose multiple biochemical consequences on the ETC/OXPHOS system, which are difficult to disentangle. To address this challenge, we profiled global gene expression, bioenergetics and metabolism in muscle cells that were proliferating (myoblasts) or differentiated (myotubes) and acutely treated with a panel of small-molecule mitochondrial inhibitors. To isolate the specific biochemical pathways that trigger the ISR, we employed a suite of ‘protein prostheses’ that facilitate NADH recycling to NAD⁺, in the cytosol or in mitochondria, independent of the ETC (Titov et al., 2016).

Our systematic analysis reveals that multiple mechanisms can link mitochondrial dysfunction to ISR activation. In proliferating myoblasts, we show that ETC inhibition elevates the mitochondrial and cytosolic NADH/NAD⁺ ratios, hindering aspartate synthesis and ultimately depleting asparagine, which activates the ISR via the eIF2α kinase GCN2. In myotubes, we find that inhibition of ATP synthase activates the ISR via a distinct mechanism related to mitochondrial inner-membrane hyperpolarization. Our results reject the notion of a universal trigger of the ISR in mitochondrial dysfunction, and rather, reveal multiple paths to its activation that depend both on the nature of the mitochondrial defect and on the metabolic state of the cell.

We sought to interrogate the genomic response to mitochondrial dysfunction and its dependence on the metabolic state of the cell. To this end, we utilized proliferating C2C12 mouse myoblasts, which can be induced to exit the cell cycle and then terminally differentiate into myotubes (Yaffe and Saxel, 1977; Blau et al., 1985; Figure 1A). Differentiation triggers mitochondrial biogenesis and promotes oxidative metabolism as the cells shift from a primary focus on nutrient uptake and biosynthesis to self-maintenance and specialized functions (Moyes et al., 1997; Leary et al., 1998; Casadei et al., 2009; Remels et al., 2010; Sin et al., 2016; Vander Heiden et al., 2009; Lemons et al., 2010).

Figure 1

Download asset Open asset

We acutely treated myoblasts and myotubes with inhibitors of complex I (piericidin), complex III (antimycin) or ATP synthase (oligomycin) (Figure 1B) in media lacking pyruvate and uridine, to avoid masking known metabolic vulnerabilities of ETC-compromised cells (Morais et al., 1980; King and Attardi, 1989) (Materials and methods). We confirmed the inhibitors exerted the expected effects on respiration (Figure 1C). Complex I or complex III inhibition abrogated mitochondrial oxygen consumption while cells treated with the ATP synthase inhibitor retained residual respiration, not coupled to ATP synthesis, often termed oligomycin-resistant respiration or leak respiration (Jastroch et al., 2010; Divakaruni and Brand, 2011). Myotube mitochondria showed less leak respiration, indicative of tighter coupling (Sin et al., 2016).

We next performed RNA-sequencing to profile global gene expression changes following 10 hr of treatment, roughly corresponding to the duration of the myoblast cell cycle. Principal component analysis (PCA) of the combined data from myoblasts and myotubes suggested marked differences in their response to mitochondrial inhibition but the strongest trend was the fundamental distinction between the cell states (Figure 1D). We therefore proceeded to analyze the results separately for myoblasts and for myotubes.

Mechanistically distinct inhibitors of mitochondria trigger the ISR in myoblasts

PCA of myoblast gene expression revealed a dominant first principal component (PC1; 57% of the variance) along which inhibited cells progressed, with piericidin and antimycin exerting a more pronounced effect than oligomycin (Figure 2A; Supplementary file 1). To gain insight into genes driving variation along PC1, we subjected the 500 genes with the most positive weights (upregulated along PC1) and, separately, the 500 genes with the most negative weights (downregulated) to cis-regulatory analysis (Janky et al., 2014) (Materials and methods). We also performed gene set enrichment analysis (GSEA) (Mootha et al., 2003; Subramanian et al., 2005) of REACTOME pathways (Croft et al., 2014) using PC1 weights as the gene ranks (Materials and methods).

Figure 2 with 1 supplement see all

Download asset Open asset

Figure 2—source data 1

Gene set enrichment analysis.

https://cdn.elifesciences.org/articles/49178/elife-49178-fig2-data1-v1.xlsx

Download elife-49178-fig2-data1-v1.xlsx

Both approaches converged on activation of the ISR as a major trend driving gene expression following inhibitor treatments. Cis-regulatory analysis identified binding motifs for the ISR master regulator ATF4 as the most enriched in promoters of genes upregulated along PC1 (Figure 2B; Supplementary file 2), while GSEA highlighted pathways typically upregulated as part of the ISR, including cytosolic tRNA synthetases and translation factors, amino acid transport and biosynthesis genes, and additional ISR regulators (Harding et al., 2003; Han et al., 2013; Figure 2C).

At the same time, the analyses revealed downregulation of genes linked to cell proliferation. Promoters of downregulated genes were enriched for motifs or ChIP-seq peaks of E2F-family transcription factors, master regulators of the cell cycle (Johnson et al., 1993; Helin, 1998; Ren et al., 2002; Fischer and Müller, 2017), and of SREBP-1/2, regulators of cholesterol and lipid metabolism (Yokoyama et al., 1993; Hua et al., 1993; Wang et al., 1994; Horton et al., 2002; Figure 2B; Supplementary file 2). The cell cycle, DNA replication and cholesterol biosynthesis pathways also emerged as the most sharply depressed in the GSEA results (Figure 2C). This is consistent with the proliferative defect ETC inhibition is expected to impose in our media conditions.

We generated a volcano plot relating each gene’s magnitude and significance of association with PC1 (Materials and methods). We then annotated it with verified target genes of ATF4 and DDIT3 derived from ChIP-seq data (Han et al., 2013), and with members of the REACTOME cell cycle and cholesterol pathways (Figure 2D; Supplementary file 1). The result demonstrated the striking enrichment of these categories among differentially expressed genes. Expression changes of top genes associated with PC1 from the enriched categories further illustrated that the transcriptional signatures of ISR activation (Figure 2E) and impaired proliferation (Figure 2F) mirrored one another (Hamanaka et al., 2005).

A large fraction of ISR target genes displayed the gradation of induction with the different inhibitors reflected along PC1, that is antimycin > piericidin > oligomycin (Group 1 in Figure 2—figure supplement 1A). Other targets, however, showed comparable induction across the inhibitors (Group 2) and a minority even showed the reverse gradation (Group 3). These patterns suggest complex cross-regulation of some ISR targets and underscore the non-equivalence of different modes of mitochondrial dysfunction. Nevertheless, the transcriptional signatures we observed were accompanied in all cases by eIF2α phosphorylation and ATF4 protein accumulation (Figure 2—figure supplement 1B).

Oxidizing cytosolic NADH/NAD⁺ is sufficient to ablate ISR activation by complex I inhibition in myoblasts

In myoblasts, complex I or complex III inhibition triggered the ISR more potently than ATP synthase inhibition. We therefore reasoned that a decrease in ATP levels due to breakdown of OXPHOS was less likely to play the operative role in ISR activation, whereas impaired NADH oxidation (‘reductive stress’) presented a more compelling candidate. To explore this possibility, we generated myoblasts expressing LbNOX, a bacterial water-forming NADH oxidase that directly converts NADH to NAD⁺ independent of the ETC (Titov et al., 2016; Figure 3A, Figure 3—figure supplement 1A). We also generated cells expressing mitoLbNOX, a variant of LbNOX targeted to the mitochondrial matrix (Titov et al., 2016; Figure 3A, Figure 3—figure supplement 1A). Finally, we generated cells expressing NDI1, a piericidin-resistant yeast protein that substitutes for complex I in transferring electrons from NADH to coenzyme Q (CoQ) and thus facilitates both continued NADH oxidation and ATP synthesis by OXPHOS (Titov et al., 2016; De Vries et al., 1992; Seo et al., 1998; Seo et al., 2000; Figure 3B, Figure 3—figure supplement 1A).

Figure 3 with 1 supplement see all

Download asset Open asset

We confirmed that complex I or complex III inhibition elevated whole-cell NADH/NAD⁺, which primarily reflects the mitochondrial ratio (Titov et al., 2016; Sies, 1982; Eng et al., 1989), more so than ATP synthase inhibition (Figure 3C), consistent with leak respiration in the latter case. The increase in whole-cell NADH/NAD⁺ was prevented in all cases by mitoLbNOX, as expected, whereas LbNOX provided only limited relief given the smaller cytosolic contribution to the whole-cell signal.

We also measured the secreted [lactate]/[pyruvate] ratio, a proxy for cytosolic NADH/NAD⁺ through equilibration by the lactate dehydrogenase (LDH) reaction (Williamson et al., 1967; Figure 3D). The results aligned with the predicted effects of the inhibitors on the malate-aspartate shuttle and the glycerol-3-phosphate shuttle, which facilitate oxidation of cytosolic reducing equivalents in mitochondria (Dawson, 1979; Safer et al., 1971). Thus, the increase in mitochondrial NADH/NAD⁺ in either piericidin- or antimycin-treated cells is expected to stall reactions coupled to this ratio in the tricarboxylic acid (TCA) cycle that are required for malate-aspartate shuttle activity (LaNoue and Williamson, 1971). However, only antimycin overly-reduces the CoQ pool, which blocks the TCA cycle at complex II independently of NADH/NAD⁺ and additionally inhibits the glycerol-3-phosphate shuttle (Mráček et al., 2013; Figure 3—figure supplement 1B).

LbNOX expression was able to maintain a low [lactate]/[pyruvate] ratio in all cases, as it directly oxidizes the cytosol (Figure 3D). mitoLbNOX also buffered the impact of piericidin and oligomycin but failed to effectively oxidize the cytosol during antimycin treatment. This result demonstrated that mitoLbNOX affected cytosolic NADH/NAD⁺ through the redox shuttles, both of which are inhibited by antimycin’s effect on CoQ in a manner that mitoLbNOX cannot resolve.

Strikingly, LbNOX expression was sufficient to almost completely ablate ISR activation, represented by the Ddit3 transcript, upon complex I or complex III inhibition but only partially mitigated ISR activation by ATP synthase inhibition (Figure 3E). mitoLbNOX also significantly attenuated ISR activation during complex I inhibition but proved less effective during complex III inhibition, possibly due to its failure to fully oxidize the cytosol in this case.

We performed RNA-sequencing to ascertain the global effects of maintaining compartment-specific NADH oxidation during inhibitor treatments. PCA of the combined data from control myoblasts (shown in Figure 2) and myoblasts expressing LbNOX, mitoLbNOX or NDI1 recapitulated a first principal component driven by the ISR and proliferative gene expression. The effects following inhibitor treatments were broadly in line with the results for Ddit3. During complex I inhibition (red), oxidizing the cytosol with LbNOX (square), or the matrix and the cytosol with mitoLbNOX (triangle), was almost as effective in preventing gene expression changes along PC1 as fully maintaining OXPHOS with NDI1 (diamond) (Figure 3F; Supplementary file 1). Thus, impaired NADH oxidation was the primary trigger of ISR-related gene expression in myoblasts and correcting the NADH imbalance in the cytosol was sufficient to prevent this, which was also evident following 48 hr of inhibiting mitochondrial protein synthesis with chloramphenicol (Figure 3G).

Complex I inhibition in myoblasts activates the eIF2α kinase GCN2 due to an asparagine deficiency

We focused our mechanistic investigation on the functional consequence of complex I inhibition that triggered the ISR, as the response was most effectively blunted by oxidizing cytosolic NADH in this case. One possibility was that glycolysis was inhibited by elevated cytosolic NADH/NAD⁺, limiting the cells’ ability to defend their adenylate energy charge in the absence of OXPHOS. Using lactate secretion as a proxy for glycolytic flux, we found that LbNOX did modestly stimulate glycolysis (Figure 4A, Figure 4—figure supplement 1A). However, this did not translate into an improved energy charge, and in fact, the opposite was true (Figure 4B, Figure 4—figure supplement 1B).

Figure 4 with 1 supplement see all

Download asset Open asset

Figure 4—source data 1

Metabolite profiling data.

https://cdn.elifesciences.org/articles/49178/elife-49178-fig4-data1-v1.xlsx

Download elife-49178-fig4-data1-v1.xlsx

Another possibility was that elevated mitochondrial and cytosolic NADH/NAD⁺ depleted a critical nutrient, which then triggered the ISR. We performed intracellular metabolite profiling on control cells or LbNOX cells acutely treated with piericidin (Figure 4C, Figure 4—figure supplement 1C). The amino acids aspartate and its derivative asparagine, alongside related TCA cycle intermediates, emerged among the top metabolites depleted by piericidin in a manner responsive to oxidizing the cytosol. This result is consistent with the contribution to aspartate synthesis of the mitochondrial and cytosolic NAD⁺-linked malate dehydrogenase (MDH) reactions that yield its precursor, oxaloacetate (Birsoy et al., 2015; Sullivan et al., 2015; Chen et al., 2016). Absolute quantification confirmed a ~ 16 fold drop in aspartate within 1 hr of piericidin treatment in control cells compared with only a 2.5-fold drop in LbNOX cells (Figure 4D, Figure 4—figure supplement 1D).

Amino acid deficiency is a canonical ISR trigger through the eIF2α kinase GCN2, which is activated due to uncharged tRNA (Hinnebusch, 1984; Dever et al., 1992; Wek et al., 1995; Berlanga et al., 1999; Zhang et al., 2002; Castilho et al., 2014; Inglis et al., 2019; Harding et al., 2019). If amino acid deficiency triggers the ISR following complex I inhibition in myoblasts, then correcting the deficiency should abrogate the response. We began by adding aspartate since the magnitude of its depletion was greater and its addition also allows the cells to partially restore asparagine (Figure 4E, Figure 4—figure supplement 1E). Indeed, 10 mM aspartate significantly attenuated ISR activation upon complex I inhibition, though not to the same extent as LbNOX (Figure 4F, Figure 4—figure supplement 1F–I). This concentration was required since most mammalian cells do not efficiently take up aspartate (Birsoy et al., 2015). Importantly, aspartate addition did not indirectly oxidize cytosolic NADH/NAD⁺ (Figure 4G) and was insufficient to appreciably restore cell proliferation (Figure 4H). Aspartate also attenuated ISR-related gene expression in C2C12 myoblasts engineered with a genetic defect in complex I (Vafai et al., 2016), where reductive stress was induced by pyruvate withdrawal (Figure 4I), as well as in piericidin-treated primary human myoblasts (Figure 4J) and primary mouse embryonic fibroblasts (Figure 4—figure supplement 1J).

To test whether ISR activation by complex I inhibition involved GCN2 activity, we used a recently described specific, small-molecule, ATP-competitive inhibitor of the kinase (GCN2iB) (Nakamura et al., 2018). Indeed, co-treatment with GCN2iB significantly suppressed ISR gene expression in response to complex I inhibition but had no effect on ISR activation in response to endoplasmic reticulum (ER) stress induced by tunicamycin (Figure 4K). The converse was true when we inhibited the ER-resident eIF2α kinase, PERK (Figure 4—figure supplement 1K; Harding et al., 1999; Axten et al., 2013).

Finally, we wished to examine how GCN2 sensed the amino acid deficiency. Using autophosphorylation at Threonine-898 as a readout of kinase activation (Romano et al., 1998), we observed that 6 hr of complex I inhibition resulted in marked GCN2 activation, which was partially attenuated by supplementing aspartate (Figure 4L). Strikingly, asparagine alone abrogated GCN2 activation with no discernible additive effect of aspartate, suggesting the drop in asparagine was the most proximal activating signal. As expected, LbNOX expression, which enables synthesis of both amino acids during complex I inhibition, effectively prevented GCN2 activation, while GCN2iB suppressed autophosphorylation both at baseline and upon piericidin treatment.

The effects of the same interventions on eIF2α phosphorylation, the event downstream of GCN2 activation, were notably less pronounced, especially given the narrow dynamic range of this signal. We observed clear attenuation of eIF2α phosphorylation upon piericidin treatment in the case of LbNOX expression, though the rescue was still incomplete (Figure 4L, Figure 4—figure supplement 1L). ATF4 protein levels largely tracked the degree of GCN2 activation (Figure 4L) and this was reflected at the level of transcriptional ISR targets at the same time-point (Figure 4M). GCN2iB completely prevented ATF4 protein accumulation despite some residual eIF2α phosphorylation (Figure 4L), suggesting GCN2 was required to attain the threshold phosphorylation level that elicits ATF4 translation. Collectively, these experiments indicate that in myoblasts, the rise in the NADH/NAD⁺ ratio is a major driver of ISR-related gene expression following complex I inhibition, as it limits biosynthesis of aspartate, depletes asparagine and activates GCN2 (Figure 4N).

ATP synthase inhibition potently triggers the ISR in myotubes while ETC inhibition neither depletes asparagine nor activates the response

We next examined the effects of inhibitor treatments in myotubes. In contrast to myoblasts, myotubes only experienced significant gene expression changes upon ATP synthase inhibition (PC1; 50% of the variance) (Figure 5A; Supplementary file 1), driven once more by ISR activation (Figure 5B), whereas ETC inhibition had little effect. The shift in the pattern of ISR activation was already evident as soon as 24 hr after the switch to low serum, when cells are largely post-mitotic but far from differentiated (Figure 5—figure supplement 1A).

Figure 5 with 1 supplement see all

Download asset Open asset

To interrogate why myotubes did not trigger the ISR upon ETC inhibition, we again measured compartment-specific NADH/NAD⁺. Myotubes did experience a significant increase in both the mitochondrial and the cytosolic ratio during ETC inhibition (Figure 5C,D). However, the ratios were not tightly linked, as in myoblasts. The severity of NADH imbalance across the inhibitors was discordant between the compartments and oxidizing mitochondrial NADH with mitoLbNOX failed to oxidize cytosolic NADH/NAD⁺. These results suggest myotubes did not rely on complex I to oxidize cytosolic reducing equivalents via the malate-aspartate shuttle. Rather, cytosolic NADH/NAD⁺ likely increased due to activation of glycolysis, evidenced by a ~ 75% rise in lactate secretion (Figure 5E), that was triggered by the drop in the energy charge regardless of the specific inhibitor used (Figure 5F). The glycerol-3-phosphate shuttle, which is uniquely sensitive to antimycin, remained operative (Figure 5D).

We next wondered how the altered metabolic state of myotubes impacted the fate of the amino acids aspartate and asparagine, whose depletion triggered the ISR in myoblasts. Despite elevated mitochondrial and cytosolic NADH/NAD⁺, complex I or complex III inhibition caused only a modest decrease (2-fold and 4-fold, respectively) in intracellular aspartate whereas ATP synthase inhibition even led to a slight accumulation (Figure 5G). None of the treatments depleted asparagine, which in fact accumulated (Figure 5H), possibly reflecting elevated cytosolic aspartate as asparagine synthesis occurs in the cytosol. The absence of asparagine deficiency likely explains why myotubes do not activate the ISR when complex I or complex III is inhibited. Myotubes also failed to trigger the ISR after mitochondrial protein synthesis was blocked for 48 hr (Figure 5—figure supplement 1B).

Several recent studies have reported activation of the integrated stress response (ISR) during mitochondrial dysfunction, however, tracing the underlying mechanisms has proved challenging. Here, we interrogated this response in two cell states, proliferating myoblasts and differentiated myotubes, by employing a battery of small-molecule inhibitors of mitochondria in combination with genetic and chemical tools for selectively buffering their effects. A chief result of this work is that there is no universal mechanism linking mitochondrial dysfunction to ISR activation but, rather, manifold paths that depend on the nature of the mitochondrial defect and on the metabolic state of the cell.

Our results in proliferating myoblasts mechanistically relate two recently recognized consequences of ETC dysfunction: a defect in aspartate biosynthesis and ISR activation. Aspartate is largely produced from TCA cycle-derived oxaloacetate (OAA) but elevated mitochondrial NADH/NAD⁺ blocks the oxidative TCA cycle when complex I is inhibited (Chen et al., 2016). OAA must then be obtained by other means, which in myoblasts depended on correcting the concomitant rise in cytosolic NADH/NAD⁺, thus tilting the MDH1 reaction toward OAA (Birsoy et al., 2015; Sullivan et al., 2015). Absent this, we found the aspartate deficiency triggered the ISR, at least initially due to depletion of its derivative asparagine that was sensed by the eIF2α kinase GCN2 (Figure 4C–M). The cytosolic aspartate and asparagine biosynthesis enzymes are both ISR targets (Fujita et al., 2007; Harding et al., 2003; Han et al., 2013), suggesting a homeostatic logic to the response.

Supplementation with asparagine alone, which cannot be converted to aspartate in most mammalian cells (Pavlova et al., 2018), was sufficient to abrogate GCN2 activation (Figure 4L). That GCN2 did not directly sense the profound aspartate depletion seems surprising. This result may be explained by the fact that while the K_M values for aspartate and asparagine of their respective cytosolic tRNA synthetases are similar (~15–30 μM) (Bour et al., 2009; Messmer et al., 2009; Andrulis et al., 1978), the cellular concentrations of these amino acids are orders of magnitude apart. Aspartate is estimated at ~5–10 mM whereas asparagine is much closer to the K_M, at ~100–200 μM (Chen et al., 2016; Park et al., 2016). Thus, even a large fold-change drop in aspartate would not compromise its cognate tRNA charging but a smaller drop in asparagine would, activating GCN2. The K_M for aspartate of asparagine synthetase is much higher (~1 mM) (Horowitz and Meister, 1972; Ciustea et al., 2005), so aspartate deficiency readily depletes asparagine (Figure 4E). We conclude asparagine tRNA charging is a sensitive sensor of NADH reductive stress in proliferating cells.

We note that oxidizing cytosolic NADH/NAD⁺ using LbNOX attenuated the ISR better than aspartate or asparagine (Figure 4F,L,M), suggesting eIF2α kinases may be attuned to additional consequences of reductive stress. Moreover, LbNOX cells still showed residual ISR activation (Figure 4L, Figure 4—figure supplement 1L), likely due to reasons beyond reductive stress. However, our results suggest threshold and non-linear effects along the ISR pathway so that NADH reductive stress was the primary driver of ISR-related gene expression.

Surprisingly, we also found that NADH reductive stress was a key modulator of an interaction between the ISR and p53 during complex III inhibition in myoblasts. The pyrimidine deficiency resulting from an overly-reduced CoQ triggered p53 to shut down ISR gene expression only when cytosolic reductive stress was resolved (Figure 3G). It is likely that the break on DNA replication imposed by reductive stress prevented the pyrimidine deficiency from giving rise to DNA damage, so p53 was not activated. Alternatively, cytosolic NADH/NAD⁺ may regulate p53 itself, possibly via NAD(P)H:quinone oxidoreductase 1 (NQO1) (Khutornenko et al., 2010; Asher et al., 2001; Asher et al., 2002), which could have implications for cancer biology.

The mapping between mitochondrial perturbation and ISR activation changed in non-dividing cells (Figure 1D, Figure 5B, Figure 5—figure supplement 1A). The ISR was not triggered by ETC inhibition in myotubes (Figure 5B), in line with a much smaller drop in aspartate and no drop in asparagine (Figure 5G,H). This result could be explained by reduced demand for these amino acids for protein and nucleotide biosynthesis (Clissold and Cole, 1973; Krauter et al., 1979; Bowman, 1987; Larson et al., 1993; Zahradka et al., 1991; Frangini et al., 2013; Talvas et al., 2006), and by increased capacity for amino acid turnover or scavenging (Deval et al., 2008; Sadiq et al., 2007), in myotubes relative to myoblasts. Moreover, myoblasts relied on complex I to oxidize cytosolic reducing equivalents via the malate-aspartate shuttle whereas this was absent in myotubes (Figure 3D, Figure 5D), consistent with observations in skeletal muscle in vivo (Sahlin et al., 1987; MacDonald and Marshall, 2000; Alfadda et al., 2004). Myotubes did exhibit elevated cytosolic NADH/NAD⁺ upon complex I inhibition but this was likely due to activation of glycolysis (Figure 5E). Conversion of glucose to lactate is net redox neutral at steady-state but elevated NADH/NAD⁺ can emerge when flux through glyceraldehyde 3-phosphate dehydrogenase (GAPDH) acutely rises or through siphoning of intermediates between GAPDH and LDH (Noor et al., 2013; Shestov et al., 2014).

Myotubes activated the ISR upon ATP synthase inhibition (Figure 5B), independently of a drop in ATP (Figure 5F) or impaired NADH oxidation (Figure 5C,D). The response was attenuated by eliminating residual respiration or by mild depolarization (Figure 5I, Figure 5—figure supplement 1C,E), implicating membrane potential in the signal relay. In respiring cells, oligomycin typically hyperpolarizes the inner-membrane as it blocks a major consumer of the proton gradient (Brand and Nicholls, 2011). Eliminating residual respiration relieves hyperpolarization by preventing proton pumping while depolarization involves facilitated proton re-entry into the matrix. This result is reminiscent of another case we recently described where inhibition of complex I ameliorated proliferative and metabolic defects due to ATP synthase inhibition, in part by relieving hyperpolarization (To et al., 2019). The link to hyperpolarization may explain why this route to the ISR is more prominent in myotubes, which exhibit increased and tightly coupled OXPHOS, though it likely plays a role in oligomycin-treated myoblasts as well. We note that severe depolarization also triggered the ISR in myotubes (Figure 5—figure supplement 1C).

While this paper was in revision, Guo et al. and Fessler et al. reported that the eIF2α kinase HRI potently triggers the ISR in response to either ATP synthase inhibition or severe depolarization (Fessler et al., 2020; Guo et al., 2020), in agreement with a previous study in the latter case (Taniuchi et al., 2016). HRI activation depended on processing of the inner-membrane protein DELE1 by the inner-membrane protease OMA1 (Fessler et al., 2020; Guo et al., 2020). It is tempting to speculate this mechanism is operative in our system, as OMA1 has been shown to respond to both depolarization and hyperpolarization (Ehses et al., 2009; Baker et al., 2014; Zhang et al., 2014), consistent with our observation that perturbation of membrane potential in either direction triggers the response. How such opposite effects converge in terms of signaling is unclear but our results suggest the common denominator is not, as Fessler et al. proposed, the drop in ATP (Figure 5F,I, Figure 5—figure supplement 1C,E).

Our results exclude mitochondrial processes that do not seem to be involved in ISR activation. The response was not activated simply due to the effects of OXPHOS inhibition on energy metabolism, so long as glucose was available. Similarly, we did not observe contributions to ISR activation by metabolic consequences exclusively related to elevated intra-mitochondrial NADH/NAD⁺. And blockade of mtDNA-encoded protein synthesis did not appear to be directly monitored in either cell state (Figure 3G, Figure 5—figure supplement 1B). The advantage of our cellular system is that so many parameters can be carefully controlled, however, it has important limitations: (i) chemical ETC inhibition is an imperfect model for genetic defects, which may impact multiple complexes and act over longer time scales, and (ii) cell culture conditions represent an artificial nutrient milieu, do not model interactions with other cell types and do not subject the cells to physiological workloads.

Our study demonstrates that multiple paths connect mitochondrial dysfunction to the ISR, depending on the combination of the defect and the metabolic state of the cell. This framework may prove useful in explaining variability in ISR activation across cell types and stressors and in dissecting the logic of the ISR in mitochondrial disorders. There is controversy over whether the ISR is activated in vivo directly by mtDNA expression defects or by ETC/OXPHOS defects (Kühl et al., 2017; Dogan et al., 2014; Lehtonen et al., 2016). Our results help address it by defining mechanisms through which the latter trigger the response. We note pyruvate therapy, which serves to regenerate NAD⁺, was recently shown to decrease serum GDF15, a circulating marker of the ISR, in mitochondrial disease patients (Koga et al., 2019), providing rich in vivo support for our identification of NADH imbalance as a trigger of the ISR. Further study of ISR activation and its consequences in the context of mitochondrial dysfunction may help define ways to therapeutically modulate the response.

Sequencing data have been deposited in GEO under accession code GSE132234.

1. 1. Mick E
   2. Titov DV
   3. Skinner OS
   4. Sharma R
   5. Jourdain AA
   6. Mootha VK

   (2020) NCBI Gene Expression Omnibus

   ID GSE132234. Distinct mitochondrial defects trigger the integrated stress response depending on the metabolic state of the cell.

   https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE132234

1. 1. Alcázar-Fabra M
   2. Navas P
   3. Brea-Calvo G

   (2016) Coenzyme Q biosynthesis and its role in the respiratory chain structure

   Biochimica Et Biophysica Acta (BBA) - Bioenergetics 1857:1073–1078.

   https://doi.org/10.1016/j.bbabio.2016.03.010

   • Google Scholar
2. 1. Alfadda A
   2. DosSantos RA
   3. Stepanyan Z
   4. Marrif H
   5. Silva JE

   (2004) Mice with deletion of the mitochondrial glycerol-3-phosphate dehydrogenase gene exhibit a thrifty phenotype: effect of gender

   American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 287:R147–R156.

   https://doi.org/10.1152/ajpregu.00103.2004

   • Google Scholar
3. 1. Andrulis IL
   2. Chiang CS
   3. Arfin SM
   4. Miner TA
   5. Hatfield GW

   (1978)

   Biochemical characterization of a mutant asparaginyl-tRNA synthetase from chinese hamster ovary cells

   The Journal of Biological Chemistry 253:58–62.

   • PubMed
   • Google Scholar
4. 1. Area-Gomez E
   2. Guardia-Laguarta C
   3. Schon EA
   4. Przedborski S

   (2019) Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas

   Journal of Clinical Investigation 129:34–45.

   https://doi.org/10.1172/JCI120848

   • PubMed
   • Google Scholar
5. 1. Asher G
   2. Lotem J
   3. Cohen B
   4. Sachs L
   5. Shaul Y

   (2001) Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1

   PNAS 98:1188–1193.

   https://doi.org/10.1073/pnas.98.3.1188

   • PubMed
   • Google Scholar
6. 1. Asher G
   2. Lotem J
   3. Kama R
   4. Sachs L
   5. Shaul Y

   (2002) NQO1 stabilizes p53 through a distinct pathway

   PNAS 99:3099–3104.

   https://doi.org/10.1073/pnas.052706799

   • PubMed
   • Google Scholar
7. 1. Axten JM
   2. Romeril SP
   3. Shu A
   4. Ralph J
   5. Medina JR
   6. Feng Y
   7. Li WH
   8. Grant SW
   9. Heerding DA
   10. Minthorn E
   11. Mencken T
   12. Gaul N
   13. Goetz A
   14. Stanley T
   15. Hassell AM
   16. Gampe RT
   17. Atkins C
   18. Kumar R

   (2013) Discovery of GSK2656157: an optimized PERK inhibitor selected for preclinical development

   ACS Medicinal Chemistry Letters 4:964–968.

   https://doi.org/10.1021/ml400228e

   • PubMed
   • Google Scholar
8. 1. Baker MJ
   2. Lampe PA
   3. Stojanovski D
   4. Korwitz A
   5. Anand R
   6. Tatsuta T
   7. Langer T

   (2014) Stress-induced OMA1 activation and autocatalytic turnover regulate OPA1-dependent mitochondrial dynamics

   The EMBO Journal 33:578–593.

   https://doi.org/10.1002/embj.201386474

   • PubMed
   • Google Scholar
9. 1. Bao XR
   2. Ong SE
   3. Goldberger O
   4. Peng J
   5. Sharma R
   6. Thompson DA
   7. Vafai SB
   8. Cox AG
   9. Marutani E
   10. Ichinose F
   11. Goessling W
   12. Regev A
   13. Carr SA
   14. Clish CB
   15. Mootha VK

   (2016) Mitochondrial dysfunction remodels one-carbon metabolism in human cells

   eLife 5:e10575.

   https://doi.org/10.7554/eLife.10575

   • PubMed
   • Google Scholar
10. 1. Berlanga JJ
    2. Santoyo J
    3. De Haro C

    (1999) Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase

    European Journal of Biochemistry 265:754–762.

    https://doi.org/10.1046/j.1432-1327.1999.00780.x

    • PubMed
    • Google Scholar
11. 1. Birsoy K
    2. Wang T
    3. Chen WW
    4. Freinkman E
    5. Abu-Remaileh M
    6. Sabatini DM

    (2015) An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis

    Cell 162:540–551.

    https://doi.org/10.1016/j.cell.2015.07.016

    • PubMed
    • Google Scholar
12. 1. Blau HM
    2. Pavlath GK
    3. Hardeman EC
    4. Chiu CP
    5. Silberstein L
    6. Webster SG
    7. Miller SC
    8. Webster C

    (1985) Plasticity of the differentiated state

    Science 230:758–766.

    https://doi.org/10.1126/science.2414846

    • PubMed
    • Google Scholar
13. 1. Bour T
    2. Akaddar A
    3. Lorber B
    4. Blais S
    5. Balg C
    6. Candolfi E
    7. Frugier M

    (2009) Plasmodial aspartyl-tRNA synthetases and peculiarities in Plasmodium falciparum

    Journal of Biological Chemistry 284:18893–18903.

    https://doi.org/10.1074/jbc.M109.015297

    • PubMed
    • Google Scholar
14. 1. Bowman LH

    (1987) rDNA transcription and pre-rRNA processing during the differentiation of a mouse myoblast cell line

    Developmental Biology 119:152–163.

    https://doi.org/10.1016/0012-1606(87)90217-X

    • PubMed
    • Google Scholar
15. 1. Brand MD

    (2016) Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling

    Free Radical Biology and Medicine 100:14–31.

    https://doi.org/10.1016/j.freeradbiomed.2016.04.001

    • PubMed
    • Google Scholar
16. 1. Brand MD
    2. Nicholls DG

    (2011) Assessing mitochondrial dysfunction in cells

    Biochemical Journal 435:297–312.

    https://doi.org/10.1042/BJ20110162

    • PubMed
    • Google Scholar
17. 1. Bratic A
    2. Larsson NG

    (2013) The role of mitochondria in aging

    Journal of Clinical Investigation 123:951–957.

    https://doi.org/10.1172/JCI64125

    • PubMed
    • Google Scholar
18. 1. Bray NL
    2. Pimentel H
    3. Melsted P
    4. Pachter L

    (2016) Near-optimal probabilistic RNA-seq quantification

    Nature Biotechnology 34:525–527.

    https://doi.org/10.1038/nbt.3519

    • PubMed
    • Google Scholar
19. 1. Campian JL
    2. Qian M
    3. Gao X
    4. Eaton JW

    (2004) Oxygen tolerance and coupling of mitochondrial electron transport

    Journal of Biological Chemistry 279:46580–46587.

    https://doi.org/10.1074/jbc.M406685200

    • PubMed
    • Google Scholar
20. 1. Casadei L
    2. Vallorani L
    3. Gioacchini AM
    4. Guescini M
    5. Burattini S
    6. D'Emilio A
    7. Biagiotti L
    8. Falcieri E
    9. Stocchi V

    (2009) Proteomics-based investigation in C2C12 myoblast differentiation

    European Journal of Histochemistry 53:e31.

    https://doi.org/10.4081/ejh.2009.e31

    • Google Scholar
21. 1. Castilho BA
    2. Shanmugam R
    3. Silva RC
    4. Ramesh R
    5. Himme BM
    6. Sattlegger E

    (2014) Keeping the eIF2 alpha kinase Gcn2 in check

    Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research 1843:1948–1968.

    https://doi.org/10.1016/j.bbamcr.2014.04.006

    • Google Scholar
22. 1. Celardo I
    2. Lehmann S
    3. Costa AC
    4. Loh SH
    5. Miguel Martins L

    (2017) dATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective

    Cell Death & Differentiation 24:638–648.

    https://doi.org/10.1038/cdd.2016.158

    • PubMed
    • Google Scholar
23. 1. Chen WW
    2. Freinkman E
    3. Wang T
    4. Birsoy K
    5. Sabatini DM

    (2016) Absolute quantification of matrix metabolites reveals the dynamics of mitochondrial metabolism

    Cell 166:1324–1337.

    https://doi.org/10.1016/j.cell.2016.07.040

    • Google Scholar
24. 1. Chung HK
    2. Ryu D
    3. Kim KS
    4. Chang JY
    5. Kim YK
    6. Yi HS
    7. Kang SG
    8. Choi MJ
    9. Lee SE
    10. Jung SB
    11. Ryu MJ
    12. Kim SJ
    13. Kweon GR
    14. Kim H
    15. Hwang JH
    16. Lee CH
    17. Lee SJ
    18. Wall CE
    19. Downes M
    20. Evans RM
    21. Auwerx J
    22. Shong M

    (2017) Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis

    Journal of Cell Biology 216:149–165.

    https://doi.org/10.1083/jcb.201607110

    • PubMed
    • Google Scholar
25. 1. Chung NC
    2. Storey JD

    (2015) Statistical significance of variables driving systematic variation in high-dimensional data

    Bioinformatics 31:545–554.

    https://doi.org/10.1093/bioinformatics/btu674

    • PubMed
    • Google Scholar
26. 1. Ciustea M
    2. Gutierrez JA
    3. Abbatiello SE
    4. Eyler JR
    5. Richards NG

    (2005) Efficient expression, purification, and characterization of C-terminally tagged, recombinant human asparagine synthetase

    Archives of Biochemistry and Biophysics 440:18–27.

    https://doi.org/10.1016/j.abb.2005.05.023

    • PubMed
    • Google Scholar
27. 1. Clissold P
    2. Cole RJ

    (1973) Regulation of ribosomal RNA synthesis during mammalian myogenesis in culture

    Experimental Cell Research 80:159–169.

    https://doi.org/10.1016/0014-4827(73)90287-5

    • PubMed
    • Google Scholar
28. 1. Croft D
    2. Mundo AF
    3. Haw R
    4. Milacic M
    5. Weiser J
    6. Wu G
    7. Caudy M
    8. Garapati P
    9. Gillespie M
    10. Kamdar MR
    11. Jassal B
    12. Jupe S
    13. Matthews L
    14. May B
    15. Palatnik S
    16. Rothfels K
    17. Shamovsky V
    18. Song H
    19. Williams M
    20. Birney E
    21. Hermjakob H
    22. Stein L
    23. D'Eustachio P

    (2014) The reactome pathway knowledgebase

    Nucleic Acids Research 42:D472–D477.

    https://doi.org/10.1093/nar/gkt1102

    • PubMed
    • Google Scholar
29. 1. Dawson AG

    (1979) Oxidation of cytosolic NADH formed during aerobic metabolism in mammalian cells

    Trends in Biochemical Sciences 4:171–176.

    https://doi.org/10.1016/0968-0004(79)90417-1

    • Google Scholar
30. 1. De Vries S
    2. Van Witzenburg R
    3. Grivell LA
    4. Marres CA

    (1992) Primary structure and import pathway of the rotenone-insensitive NADH-ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae

    European Journal of Biochemistry 203:587–592.

    https://doi.org/10.1111/j.1432-1033.1992.tb16587.x

    • PubMed
    • Google Scholar
31. 1. Deval C
    2. Talvas J
    3. Chaveroux C
    4. Maurin AC
    5. Mordier S
    6. Cherasse Y
    7. Parry L
    8. Carraro V
    9. Jousse C
    10. Bruhat A
    11. Fafournoux P

    (2008) Amino-acid limitation induces the GCN2 signaling pathway in myoblasts but not in myotubes

    Biochimie 90:1716–1721.

    https://doi.org/10.1016/j.biochi.2008.07.004

    • PubMed
    • Google Scholar
32. 1. Dever TE
    2. Feng L
    3. Wek RC
    4. Cigan AM
    5. Donahue TF
    6. Hinnebusch AG

    (1992) Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast

    Cell 68:585–596.

    https://doi.org/10.1016/0092-8674(92)90193-G

    • PubMed
    • Google Scholar
33. 1. Divakaruni AS
    2. Brand MD

    (2011) The regulation and physiology of mitochondrial proton leak

    Physiology 26:192–205.

    https://doi.org/10.1152/physiol.00046.2010

    • PubMed
    • Google Scholar
34. 1. Dogan SA
    2. Pujol C
    3. Maiti P
    4. Kukat A
    5. Wang S
    6. Hermans S
    7. Senft K
    8. Wibom R
    9. Rugarli EI
    10. Trifunovic A

    (2014) Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart

    Cell Metabolism 19:458–469.

    https://doi.org/10.1016/j.cmet.2014.02.004

    • PubMed
    • Google Scholar
35. 1. Ehses S
    2. Raschke I
    3. Mancuso G
    4. Bernacchia A
    5. Geimer S
    6. Tondera D
    7. Martinou JC
    8. Westermann B
    9. Rugarli EI
    10. Langer T

    (2009) Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1

    The Journal of Cell Biology 187:1023–1036.

    https://doi.org/10.1083/jcb.200906084

    • PubMed
    • Google Scholar
36. 1. Eng J
    2. Lynch RM
    3. Balaban RS

    (1989) Nicotinamide adenine dinucleotide fluorescence spectroscopy and imaging of isolated cardiac myocytes

    Biophysical Journal 55:621–630.

    https://doi.org/10.1016/S0006-3495(89)82859-0

    • Google Scholar
37. 1. Evstafieva AG
    2. Garaeva AA
    3. Khutornenko AA
    4. Klepikova AV
    5. Logacheva MD
    6. Penin AA
    7. Novakovsky GE
    8. Kovaleva IE
    9. Chumakov PM

    (2014) A sustained deficiency of mitochondrial respiratory complex III induces an apoptotic cell death through the p53-mediated inhibition of pro-survival activities of the activating transcription factor 4

    Cell Death & Disease 5:e1511.

    https://doi.org/10.1038/cddis.2014.469

    • PubMed
    • Google Scholar
38. 1. Fessler E
    2. Eckl EM
    3. Schmitt S
    4. Mancilla IA
    5. Meyer-Bender MF
    6. Hanf M
    7. Philippou-Massier J
    8. Krebs S
    9. Zischka H
    10. Jae LT

    (2020) A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol

    Nature 579:433–437.

    https://doi.org/10.1038/s41586-020-2076-4

    • PubMed
    • Google Scholar
39. 1. Fischer M
    2. Müller GA

    (2017) Cell cycle transcription control: dream/MuvB and RB-E2F complexes

    Critical Reviews in Biochemistry and Molecular Biology 52:638–662.

    https://doi.org/10.1080/10409238.2017.1360836

    • PubMed
    • Google Scholar
40. 1. Frangini M
    2. Franzolin E
    3. Chemello F
    4. Laveder P
    5. Romualdi C
    6. Bianchi V
    7. Rampazzo C

    (2013) Synthesis of mitochondrial DNA precursors during Myogenesis, an analysis in purified C2C12 myotubes

    Journal of Biological Chemistry 288:5624–5635.

    https://doi.org/10.1074/jbc.M112.441147

    • PubMed
    • Google Scholar
41. 1. Frazier AE
    2. Thorburn DR
    3. Compton AG

    (2019) Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology

    Journal of Biological Chemistry 294:5386–5395.

    https://doi.org/10.1074/jbc.R117.809194

    • PubMed
    • Google Scholar
42. 1. Fujita Y
    2. Ito M
    3. Nozawa Y
    4. Yoneda M
    5. Oshida Y
    6. Tanaka M

    (2007) CHOP (C/EBP homologous protein) and ASNS (asparagine synthetase) induction in cybrid cells harboring MELAS and NARP mitochondrial DNA mutations

    Mitochondrion 7:80–88.

    https://doi.org/10.1016/j.mito.2006.11.003

    • PubMed
    • Google Scholar
43. 1. Fujita Y
    2. Ito M
    3. Kojima T
    4. Yatsuga S
    5. Koga Y
    6. Tanaka M

    (2015) GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases

    Mitochondrion 20:34–42.

    https://doi.org/10.1016/j.mito.2014.10.006

    • PubMed
    • Google Scholar
44. 1. Gaude E
    2. Frezza C

    (2014) Defects in mitochondrial metabolism and Cancer

    Cancer & Metabolism 2:10.

    https://doi.org/10.1186/2049-3002-2-10

    • PubMed
    • Google Scholar
45. 1. Goodman RP
    2. Calvo SE
    3. Mootha VK

    (2018) Spatiotemporal compartmentalization of hepatic NADH and NADPH metabolism

    Journal of Biological Chemistry 293:7508–7516.

    https://doi.org/10.1074/jbc.TM117.000258

    • PubMed
    • Google Scholar
46. 1. Gorman GS
    2. Schaefer AM
    3. Ng Y
    4. Gomez N
    5. Blakely EL
    6. Alston CL
    7. Feeney C
    8. Horvath R
    9. Yu-Wai-Man P
    10. Chinnery PF
    11. Taylor RW
    12. Turnbull DM
    13. McFarland R

    (2015) Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease

    Annals of Neurology 77:753–759.

    https://doi.org/10.1002/ana.24362

    • PubMed
    • Google Scholar
47. 1. Gorman GS
    2. Chinnery PF
    3. DiMauro S
    4. Hirano M
    5. Koga Y
    6. McFarland R
    7. Suomalainen A
    8. Thorburn DR
    9. Zeviani M
    10. Turnbull DM

    (2016) Mitochondrial diseases

    Nature Reviews Disease Primers 2:16080.

    https://doi.org/10.1038/nrdp.2016.80

    • PubMed
    • Google Scholar
48. 1. Guo X
    2. Aviles G
    3. Liu Y
    4. Tian R
    5. Unger BA
    6. Lin YT
    7. Wiita AP
    8. Xu K
    9. Correia MA
    10. Kampmann M

    (2020) Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway

    Nature 579:427–432.

    https://doi.org/10.1038/s41586-020-2078-2

    • PubMed
    • Google Scholar
49. 1. Hamanaka RB
    2. Bennett BS
    3. Cullinan SB
    4. Diehl JA

    (2005) PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway

    Molecular Biology of the Cell 16:5493–5501.

    https://doi.org/10.1091/mbc.e05-03-0268

    • PubMed
    • Google Scholar
50. 1. Han J
    2. Back SH
    3. Hur J
    4. Lin YH
    5. Gildersleeve R
    6. Shan J
    7. Yuan CL
    8. Krokowski D
    9. Wang S
    10. Hatzoglou M
    11. Kilberg MS
    12. Sartor MA
    13. Kaufman RJ

    (2013) ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death

    Nature Cell Biology 15:481–490.

    https://doi.org/10.1038/ncb2738

    • PubMed
    • Google Scholar
51. 1. Harding HP
    2. Zhang Y
    3. Ron D

    (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase

    Nature 397:271–274.

    https://doi.org/10.1038/16729

    • PubMed
    • Google Scholar
52. 1. Harding HP
    2. Novoa I
    3. Zhang Y
    4. Zeng H
    5. Wek R
    6. Schapira M
    7. Ron D

    (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells

    Molecular Cell 6:1099–1108.

    https://doi.org/10.1016/S1097-2765(00)00108-8

    • PubMed
    • Google Scholar
53. 1. Harding HP
    2. Zhang Y
    3. Zeng H
    4. Novoa I
    5. Lu PD
    6. Calfon M
    7. Sadri N
    8. Yun C
    9. Popko B
    10. Paules R
    11. Stojdl DF
    12. Bell JC
    13. Hettmann T
    14. Leiden JM
    15. Ron D

    (2003) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress

    Molecular Cell 11:619–633.

    https://doi.org/10.1016/S1097-2765(03)00105-9

    • PubMed
    • Google Scholar
54. 1. Harding HP
    2. Ordonez A
    3. Allen F
    4. Parts L
    5. Inglis AJ
    6. Williams RL
    7. Ron D

    (2019) The ribosomal P-stalk couples amino acid starvation to GCN2 activation in mammalian cells

    eLife 8:e50149.

    https://doi.org/10.7554/eLife.50149

    • PubMed
    • Google Scholar
55. 1. Helin K

    (1998) Regulation of cell proliferation by the E2F transcription factors

    Current Opinion in Genetics & Development 8:28–35.

    https://doi.org/10.1016/S0959-437X(98)80058-0

    • PubMed
    • Google Scholar
56. 1. Hinnebusch AG

    (1984) Evidence for translational regulation of the activator of general amino acid control in yeast

    PNAS 81:6442–6446.

    https://doi.org/10.1073/pnas.81.20.6442

    • PubMed
    • Google Scholar
57. 1. Horowitz B
    2. Meister A

    (1972)

    Glutamine-dependent asparagine synthetase from leukemia cells: chloride DEPENDENCE, MECHANISM OF ACTION, AND INHIBITION

    The Journal of Biological Chemistry 247:6708–6719.

    • PubMed
    • Google Scholar
58. 1. Horton JD
    2. Goldstein JL
    3. Brown MS

    (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

    Journal of Clinical Investigation 109:1125–1131.

    https://doi.org/10.1172/JCI0215593

    • PubMed
    • Google Scholar
59. 1. Hu Q
    2. Wang G

    (2016) Mitochondrial dysfunction in Parkinson's disease

    Translational Neurodegeneration 5:14.

    https://doi.org/10.1186/s40035-016-0060-6

    • PubMed
    • Google Scholar
60. 1. Hua X
    2. Yokoyama C
    3. Wu J
    4. Briggs MR
    5. Brown MS
    6. Goldstein JL
    7. Wang X

    (1993) SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element

    PNAS 90:11603–11607.

    https://doi.org/10.1073/pnas.90.24.11603

    • PubMed
    • Google Scholar
61. 1. Inglis AJ
    2. Masson GR
    3. Shao S
    4. Perisic O
    5. McLaughlin SH
    6. Hegde RS
    7. Williams RL

    (2019) Activation of GCN2 by the ribosomal P-stalk

    PNAS 116:4946–4954.

    https://doi.org/10.1073/pnas.1813352116

    • PubMed
    • Google Scholar
62. 1. Jain IH
    2. Zazzeron L
    3. Goldberger O
    4. Marutani E
    5. Wojtkiewicz GR
    6. Ast T
    7. Wang H
    8. Schleifer G
    9. Stepanova A
    10. Brepoels K
    11. Schoonjans L
    12. Carmeliet P
    13. Galkin A
    14. Ichinose F
    15. Zapol WM
    16. Mootha VK

    (2019) Leigh syndrome mouse model can be rescued by interventions that normalize brain hyperoxia, but not HIF activation

    Cell Metabolism 30:824–832.

    https://doi.org/10.1016/j.cmet.2019.07.006

    • PubMed
    • Google Scholar
63. 1. Janky R
    2. Verfaillie A
    3. Imrichová H
    4. Van de Sande B
    5. Standaert L
    6. Christiaens V
    7. Hulselmans G
    8. Herten K
    9. Naval Sanchez M
    10. Potier D
    11. Svetlichnyy D
    12. Kalender Atak Z
    13. Fiers M
    14. Marine JC
    15. Aerts S

    (2014) iRegulon: from a gene list to a gene regulatory network using large motif and track collections

    PLOS Computational Biology 10:e1003731.

    https://doi.org/10.1371/journal.pcbi.1003731

    • PubMed
    • Google Scholar
64. 1. Jastroch M
    2. Divakaruni AS
    3. Mookerjee S
    4. Treberg JR
    5. Brand MD

    (2010) Mitochondrial proton and electron leaks

    Essays in Biochemistry 47:53–67.

    https://doi.org/10.1042/bse0470053

    • PubMed
    • Google Scholar
65. 1. Johnson DG
    2. Schwarz JK
    3. Cress WD
    4. Nevins JR

    (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase

    Nature 365:349–352.

    https://doi.org/10.1038/365349a0

    • PubMed
    • Google Scholar
66. 1. Kelley DE
    2. He J
    3. Menshikova EV
    4. Ritov VB

    (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

    Diabetes 51:2944–2950.

    https://doi.org/10.2337/diabetes.51.10.2944

    • PubMed
    • Google Scholar
67. 1. Kenwood BM
    2. Weaver JL
    3. Bajwa A
    4. Poon IK
    5. Byrne FL
    6. Murrow BA
    7. Calderone JA
    8. Huang L
    9. Divakaruni AS
    10. Tomsig JL
    11. Okabe K
    12. Lo RH
    13. Cameron Coleman G
    14. Columbus L
    15. Yan Z
    16. Saucerman JJ
    17. Smith JS
    18. Holmes JW
    19. Lynch KR
    20. Ravichandran KS
    21. Uchiyama S
    22. Santos WL
    23. Rogers GW
    24. Okusa MD
    25. Bayliss DA
    26. Hoehn KL

    (2014) Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane

    Molecular Metabolism 3:114–123.

    https://doi.org/10.1016/j.molmet.2013.11.005

    • PubMed
    • Google Scholar
68. 1. Khan NA
    2. Nikkanen J
    3. Yatsuga S
    4. Jackson C
    5. Wang L
    6. Pradhan S
    7. Kivelä R
    8. Pessia A
    9. Velagapudi V
    10. Suomalainen A

    (2017) mTORC1 regulates mitochondrial integrated stress response and mitochondrial myopathy progression

    Cell Metabolism 26:419–428.

    https://doi.org/10.1016/j.cmet.2017.07.007

    • PubMed
    • Google Scholar
69. 1. Khutornenko AA
    2. Roudko VV
    3. Chernyak BV
    4. Vartapetian AB
    5. Chumakov PM
    6. Evstafieva AG

    (2010) Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway

    PNAS 107:12828–12833.

    https://doi.org/10.1073/pnas.0910885107

    • PubMed
    • Google Scholar
70. 1. King MP
    2. Attardi G

    (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

    Science 246:500–503.

    https://doi.org/10.1126/science.2814477

    • PubMed
    • Google Scholar
71. 1. Koga Y
    2. Povalko N
    3. Inoue E
    4. Nashiki K
    5. Tanaka M

    (2019) Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease

    Mitochondrion 48:11–15.

    https://doi.org/10.1016/j.mito.2019.02.001

    • PubMed
    • Google Scholar
72. 1. Krauter KS
    2. Soeiro R
    3. Nadal-Ginard B

    (1979) Transcriptional regulation of ribosomal RNA accumulation during L6E9 myoblast differentiation

    Journal of Molecular Biology 134:727–741.

    https://doi.org/10.1016/0022-2836(79)90482-0

    • PubMed
    • Google Scholar
73. 1. Kühl I
    2. Miranda M
    3. Atanassov I
    4. Kuznetsova I
    5. Hinze Y
    6. Mourier A
    7. Filipovska A
    8. Larsson NG

    (2017) Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals

    eLife 6:e30952.

    https://doi.org/10.7554/eLife.30952

    • PubMed
    • Google Scholar
74. 1. Lamech LT
    2. Haynes CM

    (2015) The unpredictability of prolonged activation of stress response pathways

    Journal of Cell Biology 209:781–787.

    https://doi.org/10.1083/jcb.201503107

    • PubMed
    • Google Scholar
75. 1. LaNoue KF
    2. Schoolwerth AC

    (1979) Metabolite transport in mitochondria

    Annual Review of Biochemistry 48:871–922.

    https://doi.org/10.1146/annurev.bi.48.070179.004255

    • PubMed
    • Google Scholar
76. 1. LaNoue KF
    2. Williamson JR

    (1971) Interrelationships between malate-aspartate shuttle and citric acid cycle in rat heart mitochondria

    Metabolism 20:119–140.

    https://doi.org/10.1016/0026-0495(71)90087-4

    • PubMed
    • Google Scholar
77. 1. Larson DE
    2. Xie W
    3. Glibetic M
    4. O'Mahony D
    5. Sells BH
    6. Rothblum LI

    (1993) Coordinated decreases in rRNA gene transcription factors and rRNA synthesis during muscle cell differentiation

    PNAS  90:7933–7936.

    https://doi.org/10.1073/pnas.90.17.7933

    • Google Scholar
78. 1. Leary SC
    2. Battersby BJ
    3. Hansford RG
    4. Moyes CD

    (1998) Interactions between bioenergetics and mitochondrial biogenesis

    Biochimica Et Biophysica Acta (BBA) - Bioenergetics 1365:522–530.

    https://doi.org/10.1016/S0005-2728(98)00105-4

    • Google Scholar
79. 1. Lehtonen JM
    2. Forsström S
    3. Bottani E
    4. Viscomi C
    5. Baris OR
    6. Isoniemi H
    7. Höckerstedt K
    8. Österlund P
    9. Hurme M
    10. Jylhävä J
    11. Leppä S
    12. Markkula R
    13. Heliö T
    14. Mombelli G
    15. Uusimaa J
    16. Laaksonen R
    17. Laaksovirta H
    18. Auranen M
    19. Zeviani M
    20. Smeitink J
    21. Wiesner RJ
    22. Nakada K
    23. Isohanni P
    24. Suomalainen A

    (2016) FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders

    Neurology 87:2290–2299.

    https://doi.org/10.1212/WNL.0000000000003374

    • PubMed
    • Google Scholar
80. 1. Lemons JM
    2. Feng XJ
    3. Bennett BD
    4. Legesse-Miller A
    5. Johnson EL
    6. Raitman I
    7. Pollina EA
    8. Rabitz HA
    9. Rabinowitz JD
    10. Coller HA

    (2010) Quiescent fibroblasts exhibit high metabolic activity

    PLOS Biology 8:e1000514.

    https://doi.org/10.1371/journal.pbio.1000514

    • PubMed
    • Google Scholar
81. 1. Lin MT
    2. Beal MF

    (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

    Nature 443:787–795.

    https://doi.org/10.1038/nature05292

    • PubMed
    • Google Scholar
82. 1. Love MI
    2. Huber W
    3. Anders S

    (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

    Genome Biology 15:550.

    https://doi.org/10.1186/s13059-014-0550-8

    • PubMed
    • Google Scholar
83. 1. Lu W
    2. Su X
    3. Klein MS
    4. Lewis IA
    5. Fiehn O
    6. Rabinowitz JD

    (2017) Metabolite measurement: pitfalls to avoid and practices to follow

    Annual Review of Biochemistry 86:277–304.

    https://doi.org/10.1146/annurev-biochem-061516-044952

    • Google Scholar
84. 1. MacDonald MJ
    2. Marshall LK

    (2000) Mouse lacking NAD⁺-linked glycerol phosphate dehydrogenase has normal pancreatic beta cell function but abnormal metabolite pattern in skeletal muscle

    Archives of Biochemistry and Biophysics 384:143–153.

    https://doi.org/10.1006/abbi.2000.2107

    • PubMed
    • Google Scholar
85. 1. Magarin M
    2. Pohl T
    3. Lill A
    4. Schulz H
    5. Blaschke F
    6. Heuser A
    7. Thierfelder L
    8. Donath S
    9. Drenckhahn JD

    (2016) Embryonic cardiomyocytes can orchestrate various cell protective mechanisms to survive mitochondrial stress

    Journal of Molecular and Cellular Cardiology 97:1–14.

    https://doi.org/10.1016/j.yjmcc.2016.04.007

    • PubMed
    • Google Scholar
86. 1. Martin J
    2. Mahlke K
    3. Pfanner N

    (1991)

    Role of an energized inner membrane in mitochondrial protein import. Delta psi drives the movement of presequences

    The Journal of Biological Chemistry 266:18051–18057.

    • PubMed
    • Google Scholar
87. 1. Martinus RD
    2. Garth GP
    3. Webster TL
    4. Cartwright P
    5. Naylor DJ
    6. Høj PB
    7. Hoogenraad NJ

    (1996) Selective induction of mitochondrial chaperones in response to loss of the mitochondrial genome

    European Journal of Biochemistry 240:98–103.

    https://doi.org/10.1111/j.1432-1033.1996.0098h.x

    • PubMed
    • Google Scholar
88. 1. Messmer M
    2. Blais SP
    3. Balg C
    4. Chênevert R
    5. Grenier L
    6. Lagüe P
    7. Sauter C
    8. Sissler M
    9. Giegé R
    10. Lapointe J
    11. Florentz C

    (2009) Peculiar inhibition of human mitochondrial aspartyl-tRNA synthetase by adenylate analogs

    Biochimie 91:596–603.

    https://doi.org/10.1016/j.biochi.2009.02.005

    • PubMed
    • Google Scholar
89. 1. Mitchell P

    (1961) Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism

    Nature 191:144–148.

    https://doi.org/10.1038/191144a0

    • PubMed
    • Google Scholar
90. 1. Mitchell P

    (1975) Protonmotive redox mechanism of the cytochrome b-c1 complex in the respiratory chain: protonmotive ubiquinone cycle

    FEBS Letters 56:1–6.

    https://doi.org/10.1016/0014-5793(75)80098-6

    • PubMed
    • Google Scholar
91. 1. Mitchell P

    (2011) Chemiosmotic coupling in oxidative and photosynthetic phosphorylation

    Biochimica Et Biophysica Acta (BBA) - Bioenergetics 1807:1507–1538.

    https://doi.org/10.1016/j.bbabio.2011.09.018

    • Google Scholar
92. 1. Miyake M
    2. Nomura A
    3. Ogura A
    4. Takehana K
    5. Kitahara Y
    6. Takahara K
    7. Tsugawa K
    8. Miyamoto C
    9. Miura N
    10. Sato R
    11. Kurahashi K
    12. Harding HP
    13. Oyadomari M
    14. Ron D
    15. Oyadomari S

    (2016) Skeletal muscle-specific eukaryotic translation initiation factor 2α phosphorylation controls amino acid metabolism and fibroblast growth factor 21-mediated non-cell-autonomous energy metabolism

    The FASEB Journal 30:798–812.

    https://doi.org/10.1096/fj.15-275990

    • PubMed
    • Google Scholar
93. 1. Mootha VK
    2. Lindgren CM
    3. Eriksson KF
    4. Subramanian A
    5. Sihag S
    6. Lehar J
    7. Puigserver P
    8. Carlsson E
    9. Ridderstråle M
    10. Laurila E
    11. Houstis N
    12. Daly MJ
    13. Patterson N
    14. Mesirov JP
    15. Golub TR
    16. Tamayo P
    17. Spiegelman B
    18. Lander ES
    19. Hirschhorn JN
    20. Altshuler D
    21. Groop LC

    (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

    Nature Genetics 34:267–273.

    https://doi.org/10.1038/ng1180

    • PubMed
    • Google Scholar
94. 1. Mootha VK
    2. Handschin C
    3. Arlow D
    4. Xie X
    5. St Pierre J
    6. Sihag S
    7. Yang W
    8. Altshuler D
    9. Puigserver P
    10. Patterson N
    11. Willy PJ
    12. Schulman IG
    13. Heyman RA
    14. Lander ES
    15. Spiegelman BM

    (2004) Erralpha and gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle

    PNAS 101:6570–6575.

    https://doi.org/10.1073/pnas.0401401101

    • PubMed
    • Google Scholar
95. 1. Morais R
    2. Gregoire M
    3. Jeannotte L
    4. Gravel D

    (1980) Chick embryo cells rendered respiration-deficient by chloramphenicol and ethidium bromide are auxotrophic for pyrimidines

    Biochemical and Biophysical Research Communications 94:71–77.

    https://doi.org/10.1016/S0006-291X(80)80189-6

    • PubMed
    • Google Scholar
96. 1. Moyes CD
    2. Mathieu-Costello OA
    3. Tsuchiya N
    4. Filburn C
    5. Hansford RG

    (1997) Mitochondrial biogenesis during cellular differentiation

    American Journal of Physiology-Cell Physiology 272:C1345–C1351.

    https://doi.org/10.1152/ajpcell.1997.272.4.C1345

    • Google Scholar
97. 1. Mráček T
    2. Drahota Z
    3. Houštěk J

    (2013) The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues

    Biochimica Et Biophysica Acta (BBA) - Bioenergetics 1827:401–410.

    https://doi.org/10.1016/j.bbabio.2012.11.014

    • PubMed
    • Google Scholar
98. 1. Nakamura A
    2. Nambu T
    3. Ebara S
    4. Hasegawa Y
    5. Toyoshima K
    6. Tsuchiya Y
    7. Tomita D
    8. Fujimoto J
    9. Kurasawa O
    10. Takahara C
    11. Ando A
    12. Nishigaki R
    13. Satomi Y
    14. Hata A
    15. Hara T

    (2018) Inhibition of GCN2 sensitizes ASNS-low Cancer cells to asparaginase by disrupting the amino acid response

    PNAS 114:7776–7778.

    https://doi.org/10.1073/pnas.1805523115

    • Google Scholar
99. 1. Nikkanen J
    2. Forsström S
    3. Euro L
    4. Paetau I
    5. Kohnz RA
    6. Wang L
    7. Chilov D
    8. Viinamäki J
    9. Roivainen A
    10. Marjamäki P
    11. Liljenbäck H
    12. Ahola S
    13. Buzkova J
    14. Terzioglu M
    15. Khan NA
    16. Pirnes-Karhu S
    17. Paetau A
    18. Lönnqvist T
    19. Sajantila A
    20. Isohanni P
    21. Tyynismaa H
    22. Nomura DK
    23. Battersby BJ
    24. Velagapudi V
    25. Carroll CJ
    26. Suomalainen A

    (2016) Mitochondrial DNA replication defects disturb cellular dNTP pools and remodel One-Carbon metabolism

    Cell Metabolism 23:635–648.

    https://doi.org/10.1016/j.cmet.2016.01.019

    • PubMed
    • Google Scholar
100. 1. Noor E
     2. Flamholz A
     3. Liebermeister W
     4. Bar-Even A
     5. Milo R

     (2013) A note on the kinetics of enzyme action: a decomposition that highlights thermodynamic effects

     FEBS Letters 587:2772–2777.

     https://doi.org/10.1016/j.febslet.2013.07.028

     • PubMed
     • Google Scholar
101. 1. O'Hagan KA
     2. Cocchiglia S
     3. Zhdanov AV
     4. Tambuwala MM
     5. Tambawala MM
     6. Cummins EP
     7. Monfared M
     8. Agbor TA
     9. Garvey JF
     10. Papkovsky DB
     11. Taylor CT
     12. Allan BB

     (2009) PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells

     PNAS 106:2188–2193.

     https://doi.org/10.1073/pnas.0808801106

     • PubMed
     • Google Scholar
102. 1. Pakos‐Zebrucka K
     2. Koryga I
     3. Mnich K
     4. Ljujic M
     5. Samali A
     6. Gorman AM

     (2016) The integrated stress response 1374

     EMBO Reports 17:1374–1395.

     https://doi.org/10.15252/embr.201642195

     • Google Scholar
103. 1. Palam LR
     2. Baird TD
     3. Wek RC

     (2011) Phosphorylation of eIF2 facilitates ribosomal bypass of an inhibitory upstream ORF to enhance CHOP translation

     Journal of Biological Chemistry 286:10939–10949.

     https://doi.org/10.1074/jbc.M110.216093

     • PubMed
     • Google Scholar
104. 1. Papandreou I
     2. Cairns RA
     3. Fontana L
     4. Lim AL
     5. Denko NC

     (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

     Cell Metabolism 3:187–197.

     https://doi.org/10.1016/j.cmet.2006.01.012

     • PubMed
     • Google Scholar
105. 1. Park JO
     2. Rubin SA
     3. Xu YF
     4. Amador-Noguez D
     5. Fan J
     6. Shlomi T
     7. Rabinowitz JD

     (2016) Metabolite concentrations, fluxes and free energies imply efficient enzyme usage

     Nature Chemical Biology 12:482–489.

     https://doi.org/10.1038/nchembio.2077

     • PubMed
     • Google Scholar
106. 1. Pavlova NN
     2. Hui S
     3. Ghergurovich JM
     4. Fan J
     5. Intlekofer AM
     6. White RM
     7. Rabinowitz JD
     8. Thompson CB
     9. Zhang J

     (2018) As extracellular glutamine levels decline, asparagine becomes an essential amino acid

     Cell Metabolism 27:428–438.

     https://doi.org/10.1016/j.cmet.2017.12.006

     • PubMed
     • Google Scholar
107. 1. Picelli S
     2. Faridani OR
     3. Björklund AK
     4. Winberg G
     5. Sagasser S
     6. Sandberg R

     (2014) Full-length RNA-seq from single cells using Smart-seq2

     Nature Protocols 9:171–181.

     https://doi.org/10.1038/nprot.2014.006

     • PubMed
     • Google Scholar
108. 1. Quirós PM
     2. Prado MA
     3. Zamboni N
     4. D'Amico D
     5. Williams RW
     6. Finley D
     7. Gygi SP
     8. Auwerx J

     (2017) Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals

     Journal of Cell Biology 216:2027–2045.

     https://doi.org/10.1083/jcb.201702058

     • PubMed
     • Google Scholar
109. 1. Remels AHV
     2. Langen RCJ
     3. Schrauwen P
     4. Schaart G
     5. Schols AMWJ
     6. Gosker HR

     (2010) Regulation of mitochondrial biogenesis during myogenesis

     Molecular and Cellular Endocrinology 315:113–120.

     https://doi.org/10.1016/j.mce.2009.09.029

     • Google Scholar
110. 1. Ren B
     2. Cam H
     3. Takahashi Y
     4. Volkert T
     5. Terragni J
     6. Young RA
     7. Dynlacht BD

     (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints

     Genes & Development 16:245–256.

     https://doi.org/10.1101/gad.949802

     • PubMed
     • Google Scholar
111. 1. Restelli LM
     2. Oettinghaus B
     3. Halliday M
     4. Agca C
     5. Licci M
     6. Sironi L
     7. Savoia C
     8. Hench J
     9. Tolnay M
     10. Neutzner A
     11. Schmidt A
     12. Eckert A
     13. Mallucci G
     14. Scorrano L
     15. Frank S

     (2018) Neuronal Mitochondrial Dysfunction Activates the Integrated Stress Response to Induce Fibroblast Growth Factor 21

     Cell Reports 24:1407–1414.

     https://doi.org/10.1016/j.celrep.2018.07.023

     • Google Scholar
112. 1. Reznik E
     2. Wang Q
     3. La K
     4. Schultz N
     5. Sander C

     (2017) Mitochondrial respiratory gene expression is suppressed in many cancers

     eLife 6:e21592.

     https://doi.org/10.7554/eLife.21592

     • PubMed
     • Google Scholar
113. 1. Ritov VB
     2. Menshikova EV
     3. He J
     4. Ferrell RE
     5. Goodpaster BH
     6. Kelley DE

     (2005) Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes

     Diabetes 54:8–14.

     https://doi.org/10.2337/diabetes.54.1.8

     • PubMed
     • Google Scholar
114. 1. Ritov VB
     2. Menshikova EV
     3. Azuma K
     4. Wood R
     5. Toledo FGS
     6. Goodpaster BH
     7. Ruderman NB
     8. Kelley DE

     (2010) Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity

     American Journal of Physiology-Endocrinology and Metabolism 298:E49–E58.

     https://doi.org/10.1152/ajpendo.00317.2009

     • Google Scholar
115. 1. Romano PR
     2. Garcia-Barrio MT
     3. Zhang X
     4. Wang Q
     5. Taylor DR
     6. Zhang F
     7. Herring C
     8. Mathews MB
     9. Qin J
     10. Hinnebusch AG

     (1998) Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2

     Molecular and Cellular Biology 18:2282–2297.

     https://doi.org/10.1128/MCB.18.4.2282

     • PubMed
     • Google Scholar
116. 1. Sadiq F
     2. Hazlerigg DG
     3. Lomax MA

     (2007) Amino acids and insulin act additively to regulate components of the ubiquitin-proteasome pathway in C2C12 myotubes

     BMC Molecular Biology 8:23.

     https://doi.org/10.1186/1471-2199-8-23

     • PubMed
     • Google Scholar
117. 1. Safer B
     2. Smith CM
     3. Williamson JR

     (1971) Control of the transport of reducing equivalents across the mitochondrial membrane in perfused rat heart

     Journal of Molecular and Cellular Cardiology 2:111–124.

     https://doi.org/10.1016/0022-2828(71)90065-4

     • PubMed
     • Google Scholar
118. 1. Sahlin K
     2. Katz A
     3. Henriksson J

     (1987) Redox state and lactate accumulation in human skeletal muscle during dynamic exercise

     Biochemical Journal 245:551–556.

     https://doi.org/10.1042/bj2450551

     • PubMed
     • Google Scholar
119. 1. Santidrian AF
     2. Matsuno-Yagi A
     3. Ritland M
     4. Seo BB
     5. LeBoeuf SE
     6. Gay LJ
     7. Yagi T
     8. Felding-Habermann B

     (2013) Mitochondrial complex I activity and NAD+/NADH balance regulate breast Cancer progression

     Journal of Clinical Investigation 123:1068–1081.

     https://doi.org/10.1172/JCI64264

     • PubMed
     • Google Scholar
120. 1. Schapira AH

     (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease

     The Lancet Neurology 7:97–109.

     https://doi.org/10.1016/S1474-4422(07)70327-7

     • PubMed
     • Google Scholar
121. 1. Schapira AHV

     (2012) Mitochondrial diseases

     The Lancet 379:1825–1834.

     https://doi.org/10.1016/S0140-6736(11)61305-6

     • Google Scholar
122. 1. Semenza GL

     (2011) Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning

     Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research 1813:1263–1268.

     https://doi.org/10.1016/j.bbamcr.2010.08.006

     • PubMed
     • Google Scholar
123. 1. Seo BB
     2. Kitajima-Ihara T
     3. Chan EK
     4. Scheffler IE
     5. Matsuno-Yagi A
     6. Yagi T

     (1998) Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells

     PNAS 95:9167–9171.

     https://doi.org/10.1073/pnas.95.16.9167

     • PubMed
     • Google Scholar
124. 1. Seo BB
     2. Wang J
     3. Flotte TR
     4. Yagi T
     5. Matsuno-Yagi A

     (2000) Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells

     The Journal of Biological Chemistry 275:37774–37778.

     https://doi.org/10.1074/jbc.M007033200

     • PubMed
     • Google Scholar
125. Preprint

     1. Sergushichev AA

     (2016) An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation

     bioRxiv.

     https://doi.org/10.1101/060012

     • Google Scholar
126. 1. Shestov AA
     2. Liu X
     3. Ser Z
     4. Cluntun AA
     5. Hung YP
     6. Huang L
     7. Kim D
     8. Le A
     9. Yellen G
     10. Albeck JG
     11. Locasale JW

     (2014) Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step

     eLife 3:e03342.

     https://doi.org/10.7554/eLife.03342

     • Google Scholar
127. Book

     1. Sies H

     (1982)

     Metabolic Compartmentation

     Academic Press.

     • Google Scholar
128. 1. Silva JM
     2. Wong A
     3. Carelli V
     4. Cortopassi GA

     (2009) Inhibition of mitochondrial function induces an integrated stress response in oligodendroglia

     Neurobiology of Disease 34:357–365.

     https://doi.org/10.1016/j.nbd.2009.02.005

     • PubMed
     • Google Scholar
129. 1. Sin J
     2. Andres AM
     3. Taylor DJ
     4. Weston T
     5. Hiraumi Y
     6. Stotland A
     7. Kim BJ
     8. Huang C
     9. Doran KS
     10. Gottlieb RA

     (2016) Mitophagy is required for mitochondrial biogenesis and myogenic differentiation of C2C12 myoblasts

     Autophagy 12:369–380.

     https://doi.org/10.1080/15548627.2015.1115172

     • PubMed
     • Google Scholar
130. 1. Soneson C
     2. Love MI
     3. Robinson MD

     (2015) Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences

     F1000Research 4:1521.

     https://doi.org/10.12688/f1000research.7563.1

     • PubMed
     • Google Scholar
131. 1. Subramanian A
     2. Tamayo P
     3. Mootha VK
     4. Mukherjee S
     5. Ebert BL
     6. Gillette MA
     7. Paulovich A
     8. Pomeroy SL
     9. Golub TR
     10. Lander ES
     11. Mesirov JP

     (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

     PNAS 102:15545–15550.

     https://doi.org/10.1073/pnas.0506580102

     • Google Scholar
132. 1. Sullivan LB
     2. Gui DY
     3. Hosios AM
     4. Bush LN
     5. Freinkman E
     6. Vander Heiden MG

     (2015) Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells

     Cell 162:552–563.

     https://doi.org/10.1016/j.cell.2015.07.017

     • PubMed
     • Google Scholar
133. 1. Sun N
     2. Youle RJ
     3. Finkel T

     (2016) The mitochondrial basis of aging

     Molecular Cell 61:654–666.

     https://doi.org/10.1016/j.molcel.2016.01.028

     • PubMed
     • Google Scholar
134. 1. Suomalainen A
     2. Battersby BJ

     (2018) Mitochondrial diseases: the contribution of organelle stress responses to pathology

     Nature Reviews Molecular Cell Biology 19:77–92.

     https://doi.org/10.1038/nrm.2017.66

     • PubMed
     • Google Scholar
135. 1. Taivassalo T
     2. Abbott A
     3. Wyrick P
     4. Haller RG

     (2002) Venous oxygen levels during aerobic forearm exercise: an index of impaired oxidative metabolism in mitochondrial myopathy

     Annals of Neurology 51:38–44.

     https://doi.org/10.1002/ana.10027

     • PubMed
     • Google Scholar
136. 1. Talvas J
     2. Obled A
     3. Fafournoux P
     4. Mordier S

     (2006) Regulation of protein synthesis by leucine starvation involves distinct mechanisms in mouse C2C12 myoblasts and myotubes

     The Journal of Nutrition 136:1466–1471.

     https://doi.org/10.1093/jn/136.6.1466

     • PubMed
     • Google Scholar
137. 1. Taniuchi S
     2. Miyake M
     3. Tsugawa K
     4. Oyadomari M
     5. Oyadomari S

     (2016) Integrated stress response of vertebrates is regulated by four eIF2α kinases

     Scientific Reports 6:32886.

     https://doi.org/10.1038/srep32886

     • PubMed
     • Google Scholar
138. 1. Titov DV
     2. Cracan V
     3. Goodman RP
     4. Peng J
     5. Grabarek Z
     6. Mootha VK

     (2016) Complementation of mitochondrial electron transport chain by manipulation of the NAD+/NADH ratio

     Science 352:231–235.

     https://doi.org/10.1126/science.aad4017

     • PubMed
     • Google Scholar
139. 1. To TL
     2. Cuadros AM
     3. Shah H
     4. Hung WHW
     5. Li Y
     6. Kim SH
     7. Rubin DHF
     8. Boe RH
     9. Rath S
     10. Eaton JK
     11. Piccioni F
     12. Goodale A
     13. Kalani Z
     14. Doench JG
     15. Root DE
     16. Schreiber SL
     17. Vafai SB
     18. Mootha VK

     (2019) A compendium of genetic modifiers of mitochondrial dysfunction reveals Intra-organelle buffering

     Cell 179:1222–1238.

     https://doi.org/10.1016/j.cell.2019.10.032

     • PubMed
     • Google Scholar
140. 1. Turunen M
     2. Olsson J
     3. Dallner G

     (2004) Metabolism and function of coenzyme Q

     Biochimica Et Biophysica Acta (BBA) - Biomembranes 1660:171–199.

     https://doi.org/10.1016/j.bbamem.2003.11.012

     • Google Scholar
141. 1. Tyynismaa H
     2. Carroll CJ
     3. Raimundo N
     4. Ahola-Erkkilä S
     5. Wenz T
     6. Ruhanen H
     7. Guse K
     8. Hemminki A
     9. Peltola-Mjøsund KE
     10. Tulkki V
     11. Orešič M
     12. Moraes CT
     13. Pietiläinen K
     14. Hovatta I
     15. Suomalainen A

     (2010) Mitochondrial myopathy induces a starvation-like response

     Human Molecular Genetics 19:3948–3958.

     https://doi.org/10.1093/hmg/ddq310

     • Google Scholar
142. 1. Vafai SB
     2. Mevers E
     3. Higgins KW
     4. Fomina Y
     5. Zhang J
     6. Mandinova A
     7. Newman D
     8. Shaw SY
     9. Clardy J
     10. Mootha VK

     (2016) Natural product screening reveals naphthoquinone complex I bypass factors

     PLOS ONE 11:e0162686.

     https://doi.org/10.1371/journal.pone.0162686

     • PubMed
     • Google Scholar
143. 1. Vafai SB
     2. Mootha VK

     (2012) Mitochondrial disorders as windows into an ancient organelle

     Nature 491:374–383.

     https://doi.org/10.1038/nature11707

     • PubMed
     • Google Scholar
144. 1. Vander Heiden MG
     2. Cantley LC
     3. Thompson CB

     (2009) Understanding the warburg effect: the metabolic requirements of cell proliferation

     Science 324:1029–1033.

     https://doi.org/10.1126/science.1160809

     • PubMed
     • Google Scholar
145. 1. Vattem KM
     2. Wek RC

     (2004) Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells

     PNAS 101:11269–11274.

     https://doi.org/10.1073/pnas.0400541101

     • PubMed
     • Google Scholar
146. 1. Wallace DC

     (2012) Mitochondria and cancer

     Nature Reviews Cancer 12:685–698.

     https://doi.org/10.1038/nrc3365

     • PubMed
     • Google Scholar
147. 1. Wang X
     2. Sato R
     3. Brown MS
     4. Hua X
     5. Goldstein JL

     (1994) SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis

     Cell 77:53–62.

     https://doi.org/10.1016/0092-8674(94)90234-8

     • PubMed
     • Google Scholar
148. 1. Wek SA
     2. Zhu S
     3. Wek RC

     (1995) The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids

     Molecular and Cellular Biology 15:4497–4506.

     https://doi.org/10.1128/MCB.15.8.4497

     • PubMed
     • Google Scholar
149. 1. Wek RC

     (2018) Role of eIF2α kinases in translational control and adaptation to cellular stress

     Cold Spring Harbor Perspectives in Biology 10:a032870.

     https://doi.org/10.1101/cshperspect.a032870

     • PubMed
     • Google Scholar
150. 1. Wheaton WW
     2. Chandel NS

     (2011) Hypoxia. 2. hypoxia regulates cellular metabolism

     American Journal of Physiology-Cell Physiology 300:C385–C393.

     https://doi.org/10.1152/ajpcell.00485.2010

     • PubMed
     • Google Scholar
151. 1. Williamson DH
     2. Lund P
     3. Krebs HA

     (1967) The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver

     Biochemical Journal 103:514–527.

     https://doi.org/10.1042/bj1030514

     • PubMed
     • Google Scholar
152. 1. Xiao W
     2. Wang RS
     3. Handy DE
     4. Loscalzo J

     (2018) NAD(H) and NADP(H) Redox couples and cellular energy metabolism

     Antioxidants & Redox Signaling 28:251–272.

     https://doi.org/10.1089/ars.2017.7216

     • PubMed
     • Google Scholar
153. 1. Yaffe D
     2. Saxel O

     (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle

     Nature 270:725–727.

     https://doi.org/10.1038/270725a0

     • PubMed
     • Google Scholar
154. 1. Yatsuga S
     2. Fujita Y
     3. Ishii A
     4. Fukumoto Y
     5. Arahata H
     6. Kakuma T
     7. Kojima T
     8. Ito M
     9. Tanaka M
     10. Saiki R
     11. Koga Y

     (2015) Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders

     Annals of Neurology 78:814–823.

     https://doi.org/10.1002/ana.24506

     • PubMed
     • Google Scholar
155. 1. Ying W

     (2008) NAD⁺/NADH and NADP⁺/NADPH in cellular functions and cell death: regulation and biological consequences

     Antioxidants & Redox Signaling 10:179–206.

     https://doi.org/10.1089/ars.2007.1672

     • PubMed
     • Google Scholar
156. 1. Yokoyama C
     2. Wang X
     3. Briggs MR
     4. Admon A
     5. Wu J
     6. Hua X
     7. Goldstein JL
     8. Brown MS

     (1993) SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

     Cell 75:187–197.

     https://doi.org/10.1016/S0092-8674(05)80095-9

     • PubMed
     • Google Scholar
157. 1. Zahradka P
     2. Larson DE
     3. Sells BH

     (1991) Regulation of ribosome biogenesis in differentiated rat myotubes

     Molecular and Cellular Biochemistry 104:189–194.

     https://doi.org/10.1007/BF00229819

     • PubMed
     • Google Scholar
158. 1. Zhang P
     2. McGrath BC
     3. Reinert J
     4. Olsen DS
     5. Lei L
     6. Gill S
     7. Wek SA
     8. Vattem KM
     9. Wek RC
     10. Kimball SR
     11. Jefferson LS
     12. Cavener DR

     (2002) The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice

     Molecular and Cellular Biology 22:6681–6688.

     https://doi.org/10.1128/MCB.22.19.6681-6688.2002

     • PubMed
     • Google Scholar
159. 1. Zhang K
     2. Li H
     3. Song Z

     (2014) Membrane depolarization activates the mitochondrial protease OMA1 by stimulating self-cleavage

     EMBO Reports 15:576–585.

     https://doi.org/10.1002/embr.201338240

     • PubMed
     • Google Scholar
160. 1. Zhao Q
     2. Wang J
     3. Levichkin IV
     4. Stasinopoulos S
     5. Ryan MT
     6. Hoogenraad NJ

     (2002) A mitochondrial specific stress response in mammalian cells

     The EMBO Journal 21:4411–4419.

     https://doi.org/10.1093/emboj/cdf445

     • PubMed
     • Google Scholar
161. 1. Zhu A
     2. Ibrahim JG
     3. Love MI

     (2019) Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences

     Bioinformatics 35:2084–2092.

     https://doi.org/10.1093/bioinformatics/bty895

     • Google Scholar

Author details

1. Eran Mick

   1. Howard Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
   2. Broad Institute, Cambridge, United States
   3. Department of Systems Biology, Harvard Medical School, Boston, United States

   Present address

   1. Division of Infectious Diseases & Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, San Francisco, United States
   2. Chan Zuckerberg Biohub, San Francisco, United States

   Contribution

   Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing

   Competing interests

   listed as an inventor on a patent filed by Massachusetts General Hospital on the therapeutic uses of GCN2 inhibitors.

   "This ORCID iD identifies the author of this article:" 0000-0002-7299-808X

2. Denis V Titov

   1. Howard Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
   2. Broad Institute, Cambridge, United States
   3. Department of Systems Biology, Harvard Medical School, Boston, United States

   Present address

   Department of Nutritional Science and Toxicology, Department of Molecular and Cell Biology & Center for Computational Biology, University of California, Berkeley, United States

   Contribution

   Conceptualization, Resources, Methodology

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-5677-0651

3. Owen S Skinner

   1. Howard Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
   2. Broad Institute, Cambridge, United States
   3. Department of Systems Biology, Harvard Medical School, Boston, United States

   Contribution

   Resources, Data curation, Methodology

   Competing interests

   a paid consultant for Proteinaceous Inc.

   "This ORCID iD identifies the author of this article:" 0000-0002-5023-0029

4. Rohit Sharma

   1. Howard Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
   2. Broad Institute, Cambridge, United States
   3. Department of Systems Biology, Harvard Medical School, Boston, United States

   Contribution

   Resources, Data curation, Methodology

   Competing interests

   No competing interests declared

5. Alexis A Jourdain

   1. Howard Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
   2. Broad Institute, Cambridge, United States
   3. Department of Systems Biology, Harvard Medical School, Boston, United States

   Contribution

   Resources, Data curation, Methodology

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-5321-6938

6. Vamsi K Mootha

   1. Howard Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, United States
   2. Broad Institute, Cambridge, United States
   3. Department of Systems Biology, Harvard Medical School, Boston, United States

   Contribution

   Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing

   For correspondence

   vamsi@hms.harvard.edu

   Competing interests

   listed as an inventor on a patent filed by Massachusetts General Hospital on the therapeutic uses of GCN2 inhibitors, and a paid advisor to Janssen Pharmaceuticals and 5am Ventures.

   "This ORCID iD identifies the author of this article:" 0000-0001-9924-642X

• 18,631

  views

• 1,832

  downloads

• 139

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.